Publications

Mayeta Clark 2015

Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial

January 16, 2015

A large trial in nearly 2800 women showed a combination of sulphadoxine and pyrimethamine with azithromycin to decrease low birth weight and preterm birth in Papua New Guinea.

Read More

Parasite Biomass-Related Inflammation, Endothelial Activation, Microvascular Dysfunction and Disease Severity in Vivax Malaria

January 8, 2015

Plasmodium vivax can cause severe malaria, however its pathogenesis is poorly understood. In contrast to P. falciparum, circulating vivax parasitemia is low,…

Read More

Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission

November 18, 2014

This manuscript outlines the first mathematical model that explicitly models the contribution of relapsing infections to P. vivax transmission. This model has since served as the basis of more advanced models investigating both the effect of different intervention on P. vivax transmission and evolutionary advantages of different relapse phenotypes.

Read More

Immunological markers of vivax exposure and immunity: A Systematic Review and Meta-analysis

September 9, 2014

This study standardised protective immune responses across multiple populations to identify biomarkers of protective vivax immunity across populations of varying malaria transmission.

Read More

Global extent of chloroquine-resistant Plasmodium vivax a systematic review and meta-analysis

September 8, 2014

A meta-analysis of >191 clinical trials highlighting the complexity of defining P. vivax antimalarial efficacy. The paper demonstrates that the extent of chloroquine resistant P. vivax is far greater than previously appreciated

Read More

Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugs

September 1, 2014

Our invited review highlighted that current pharmacokinetic-pharmacodynamic models exclude important factors such as host immunity and complexities of drug action. We highlighted a lack of statistical rigour in parameter estimation.

Read More

Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria

July 1, 2014

This study demonstrated than human antibodies to merozoites promote opsonic phagocytosis by monocytes, which is was associated with protective immunity to malaria in Africa children. The acquisition and boosting of these antibodies was defined.

Read More

Decreasing malaria prevalence and its potential consequences for immunity in pregnant women

May 5, 2014

In Malawi and Papua New Guinea, maternal antibodies fell as malaria transmission declined, but rates of fall differed between different types of malaria antibody response.

Read More

Malaria burden and control in Bangladesh and prospects for elimination: an epidemiological and economic assessment

February 1, 2014

This original research quantifies the malaria burden and programmatic costs of malaria elimination in Bangladesh.

Read More

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy

January 17, 2014

Background Artemisinin combination therapy (ACT) is recommended for the treatment of multidrug resistant malaria in the second and third trimesters…

Read More

1 7 8 9 10